Correction (DOI:10.1016/j.jaci.2004.03.046);Response to inhaled albuterol during nocturnal asthma

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 6, 2004, Pages 1058-1062

  Hendeles, Leslie ^a,e   Beaty, Russell ^c   Ahrens, Richard ^d   Stevens, Gary ^b   Harman, Eloise M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b PC ^*  (United States)

^c Pulmon Associates of the Southeast   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

adrenergic agonists; Bronchodilator agents; bronchospasm; Clinical Research Center; CRC; dose response; MDI; Metered dose inhaler

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; NOCTURNAL ASTHMA; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SLEEP; STATISTICAL SIGNIFICANCE; SYMPTOM;

EID: 3042747328     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.02.022     Document Type: Erratum

References (24)

1. 2-agonists in individuals with asthma. Am J Respir Crit Care Med. 163:2001;474-477
2. Blake K.V., Hoppe M., Harman E., Hendeles L. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution: bioassay by histamine bronchoprovocation. Chest. 101:1992;309-315
3. Ahrens R.C., Harris J.B., Milavetz G., Annis L., Ries R. Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma. J Allergy Clin Immunol. 79:1987;876-882
4. Mellén A., Arvidsson P., Palmqvist M., Lötvall J. Equivalent bronchodilation with salbutamol given via pMDI or Turbuhaler. Am J Respir Crit Care Med. 159:1999;1663-1665
5. Hultquist C., Ahlström H., Kjellman N.I., Malmqvist L.Å, Svenonius E., Melin S. A double blind comparison between a new multidose powder inhaler (Turbuhaler) and metered dose inhaler in children with asthma. Allergy. 44:1989;467-470
6. Ventolin product information. Physicians' desk reference. 2001;1680 Medical Economics Co, Montvale (NJ)
7. Idris A.H., McDermott M.F., Raucci J.C., Morrabel A., McGorray S., Hendeles L. Emergency department treatment of severe asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest. 103:1993;665-672
8. Windom H.H., Burgess C.D., Crane J., Pearce N., Kwong T., Beasley R. The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J. 103:1990;205-207
9. 2-agonist. Am J Respir Crit Care Med. 160:1999;354-357
10. Creticos P.S., Adams W.P., Petty B.G., Lewis L.D., Singh G.J.P., Khattignavong A.P., et al. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered-dose inhalers. J Allergy Clin Immunol. 110:2002;713-720
11. 2-agonists in lung and heart. Am J Respir Crit Care Med. 153:1996;1489-1495
12. Jenne J.W., Shaughnessy T.K., Druz W.S., Manfredi C.J., Vestal R.E. In vivo functional antagonism between isoproterenol and bronchoconstrictants in the dog. J Appl Physiol. 63:1987;812-819
13. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 152:1995;1107-1136
14. Morris J.F., Koski A., Johnson L.C. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis. 103:1971;57-67
15. Statistical analysis system. Version 8. 2000;SAS Institute, Cary (NC)
16. National Asthma Education and Prevention Program expert panel report 2: guidelines for the diagnosis and management of asthma: clinical practice guidelines. 1997;National Institutes of Health, Bethesda (MD). p. 60. Publication 97-4051
17. Barnes P.J., Fitzgerald G.A., Dollery C.T. Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci. 62:1982;349-354
18. Szefler S.J., Ando R., Cicutto L.C., Surs W., Hill M.R., Martin R.J. Plasma histamine, epinephrine, cortisol, and leukocyte β-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther. 49:1991;59-68
19. Martin R.J., Cicutto L.C., Smith H.R., Ballard R.D., Szefler S.J. Airways inflammation in nocturnal asthma. Am Rev Respir Dis. 143:1991;351-357
20. Barnes P., FitzGerald G., Brown M., Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med. 303:1980;263-267
21. Bondesson E., Friberg K., Soliman S., Löfdahl C.G. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma. Respir Med. 92:1998;325-330
22. Ekström T., Andersson A.C., Skedinger M., Lindbladh C., Ståhl E. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler. Ann Allergy Asthma Immunol. 74:1995;328-332
23. Carlsson L.G., Arweström E., Frierg K., Källén A., Lunde H., Löfdahl C.G. Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction. Allergy. 53:1998;712-715
24. Finney D.J. Statistical methods in biological assay. 3rd ed. 1978;Charles Griffin & Co, London. p. 211-2